Experimental group:Routine treatment + Lian-Hua Qing-Ke Tablets

3 trials

Sponsors

Hebei Province Chest Hospital

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Phase 4

A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of COVID-19 patients with mild and common-type

RecruitingChiCTR2100042069

Hebei Province Chest HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2021-01-01Updated: 2022-01-18

A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of severe novel coronavirus pneumonia

RecruitingChiCTR2100042068

Hebei Province Chest HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2021-01-01Updated: 2022-01-18

A randomized, open-label, blank-controlled, multi-center clinical study for Lian-Hua Qing-Ke Tablets in the treatment of severe novel coronavirus pneumonia

RecruitingITMCTR2100004363

Hebei Province Chest HospitalNovel Coronavirus Pneumonia (COVID-19)

Start: 2021-01-01Updated: 2023-02-20

Related Papers

Efficacy and Safety of Lianhua Qingke Tablets in the Treatment of Mild and Common-Type COVID-19: A Randomized, Controlled, Multicenter Clinical Study

Evidence-based Complementary and Alternative Medicine2022-02-1012 citations